- Home
- Automated
- List of product information
- AKYNZEO CAPSULES 300MG/0.5MG [SIN15031P]
AKYNZEO CAPSULES 300MG/0.5MG [SIN15031P]
Active ingredients: AKYNZEO CAPSULES 300MG/0.5MG
Last updated 26 October 2025
Product Info
AKYNZEO CAPSULES 300MG/0.5MG
[SIN15031P]
Product information
Active Ingredient and Strength | NETUPITANT - 300 MG |
Dosage Form | CAPSULE, GELATIN COATED |
Manufacturer and Country | HELSINN BIREX PHARMACEUTICALS LTD. (INTERMEDIATE NETUPITANT TABLETS AND FINAL DRUG PRODUCT) - IRELAND |
Registration Number | SIN15031P |
Licence Holder | JUNIPER HEALTHCARE PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | A04AA55 |
1 INDICATIONS AND USAGE
AKYNZEO is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
2 DOSAGE AND ADMINISTRATION
Administration
One AKYNZEO capsule administered approximately 1 hour prior to the start of chemotherapy.
Highly Emetogenic Chemotherapy, including Cisplatin Based Chemotherapy
The recommended dosage in adults is one capsule of AKYNZEO administered approximately 1 hour prior to the start of chemotherapy with dexamethasone 12 mg administered orally 30 minutes prior to chemotherapy on day 1 and 8 mg orally once daily on days 2 to 4 [see Clinical Studies (14), Table 5) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information].
[From 14 CLINICAL STUDIES]
Anthracyclines and Cyclophosphamide Based Chemotherapy and Chemotherapy Not Considered Highly Emetogenic
The recommended dosage in adults is one capsule of AKYNZEO approximately 1 hour prior to the start of chemotherapy with dexamethasone 12 mg administered orally 30 minutes prior to chemotherapy on day 1. Administration of dexamethasone on days 2 to 4 is not necessary [see Clinical Studies (14), Table 7 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information].
[From 14 CLINICAL STUDIES]
AKYNZEO can be taken with or without food.
4 CONTRAINDICATIONS
None.